Wahli, Murielle N.
Hayoz, Stefanie
Hoch, Dennis
Ryser, Christoph O.
Hoffmann, Michèle
Scherz, Amina
Schwacha-Eipper, Birgit
Häfliger, Simon
Wampfler, Julian
Berger, Martin D.
Novak, Urban
Özdemir, Berna C. http://orcid.org/0000-0002-7380-0055
Funding for this research was provided by:
University of Bern
Article History
Received: 18 July 2022
Accepted: 15 August 2022
First Online: 23 August 2022
Declarations
:
: BCÖ declared receiving institutional honoraria for lectures and advisory boards from BMS, MSD, Merck, Ipsen, Roche, Pfizer, Novartis. SHäfliger declared receiving honoraria for advisory boards from Bayer AstraZeneca Lilly Novartis Roche Takeda; and travel fee from Amgen. All the other authors declared to have no conflict of interest in relation to this article.
: The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the institutional ethics committee of the Canton Bern (2021–01335, 30.08.2021).
: All authors approved the publication of this manuscript.